Determinants of community-acquired pneumonia among under-five children in Awi Zone, Northwest Ethiopia

Nigussie Adam Birhan1, Alene Yirsaw Workineh2, Zelalem Meraf Wolde1

  • 1Department of Statistics, College of Natural and Computational Science, Injibara University, Injibara, Ethiopia.

PubMed

Insights

Community-acquired pneumonia (CAP) affects 11.33% of children under five in Awi Zone. Key risk factors include stunting and diarrhea, while primary education and separate kitchens may be protective.

Area of Science:

  • Pediatrics
  • Public Health
  • Epidemiology

Background:

  • Community-acquired pneumonia (CAP) is a leading cause of mortality in children under five globally, disproportionately affecting low and middle-income countries.
  • In Awi Zone, understanding the prevalence and determinants of CAP is crucial for targeted public health interventions.

Purpose of the Study:

  • To determine the magnitude of community-acquired pneumonia (CAP) among children under five in Awi Zone.
  • To identify factors associated with CAP in this vulnerable population.

Main Methods:

  • A community-based cross-sectional study was conducted with 1,368 participants from March to July 2023.
  • Multistage sampling was employed, and data were analyzed using bivariable and multivariable logistic regression models.
  • Statistical significance was determined using a p-value of < 0.05.

Main Results:

  • The prevalence of community-acquired pneumonia (CAP) was found to be 11.33% (95% CI: 9.75-13.12%).
  • Significant risk factors included stunting (AOR=4.80), diarrhea (AOR=3.75), acute lower respiratory tract infection (AOR=14.57), and acute upper respiratory tract infection (AOR=9.06).
  • Primary education (AOR=0.38) and the presence of a separate kitchen (AOR=0.38) were associated with a reduced risk of CAP.

Conclusions:

  • The prevalence of CAP in under-five children in Awi Zone is substantial.
  • Interventions focusing on nutritional support, prevention and early treatment of diarrhea and respiratory infections, and reducing indoor air pollution are recommended to mitigate CAP risk.
Abstract

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
192
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
130
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
1.7K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
191
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
210
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
271